Forte provides software, consulting, services and managed infrastructure to help cancer centers, AMCs and health systems unleash their research potential.
Tomorrow, we will re-direct the Forte website to Advarra. Follow @advarra on Twitter and LinkedIn for the same great educational resources and product information. ow.ly/DkIv50CpmoJ
Ever wondered if laws similar to the EU General Data Protection Regulation (GDPR) could come to the US? Follow @advarra to stay up to date with our latest blog on the California Consumer Privacy Act’s (CCPA) impact on research. x.com/advarra/status/1319419…
Integrated research solutions are beneficial to cancer centers in more ways than one — institutions can leverage technology, services, and IRB/IBC to streamline research. ow.ly/lDcj50BH3Bn
Clinical Research Coordinators are tasked with many responsibilities throughout the day. Learn more about how to balance each role and responsibility effectively. ow.ly/1URV50By0WD
Attending our virtual Onsemble conference this October provides an opportunity to learn and collaborate with industry leaders, moving research forward. ow.ly/9tRv50Bm5ES
The COVID-19 pandemic has challenged every aspect of the clinical research industry. This new urgency has affirmed certain clinical trial innovations originally pioneered in the oncology space. ow.ly/xtjH50BaUqe
Developing and negotiating a clinical trial budget that applies Medicare’s rules and regulations involves many challenges. Find out strategies to assist with the process. ow.ly/LZM350B4VfI
Billing compliance is crucial to success in #clinicalresearch, and coverage analysis helps ensure correct billing. Our latest infographic outlines the impact coverage analysis has on billing compliance. ow.ly/GGJ250B2GPl
Since joining forces a year ago, @advarra and Forte have worked to ensure altogether better research, integrating Advarra’s CIRBI platform and Forte eReg. forteresearch.com/news/explo…
Recently, an Advarra/Forte customer utilized the Staff Augmentation Services to assist on a financials roll-out, including centralizing financial services. ow.ly/ibh450AQPx1
When supporting vendor qualification and management programs, there are different audits to consider. This article defines the differences and how to identify vendors with potential risk for your program. ow.ly/NjBw50AMJ9x
Protecting participant data is of the utmost importance in clinical research. This article breaks down risk-based monitoring, as well as other data protection terms falling underneath it. ow.ly/cNnA50AKJ0Z
This year’s 2020 AACI-CRI conference went virtual, but the research community still collaborated and shared best practices on how to keep moving clinical research forward. forteresearch.com/news/adapt…
The COVID-19 pandemic forced an era of research quickly adjusting to continue high-quality research. Most adaptations, however, have positioned research to be more patient centric, streamlined, and remote. forteresearch.com/news/fitti…
In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.” Our experts have responded to some of the most popular questions in our most recent blog. ow.ly/yy5s50Ai0NA
With research activities gradually resuming, research teams may be challenged with conducting their trials effectively and efficiently. Here’s how Staff Augmentation can help. ow.ly/9W1B50AgLye
In Advarra's latest virtual symposium, experts discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants. Our experts provided responses to some of the most popular topics in our latest blog: ow.ly/BDmD50AbIyG